The FDA is beginning to develop “a novel and tailored approach” to the regulation of medical devices that include software using artificial intelligence and machine learning. The agency initiated the development of a regulatory framework for the devices with the April 2 release of a discussion paper and a request for feedback from stakeholders. Background Artificial intelli... Read More